Average Co-Inventor Count = 3.17
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Guilford Pharmaceuticals, Inc. (21 from 98 patents)
2. Eisai Inc. (9 from 33 patents)
3. Mgi Gp, Inc. (5 from 7 patents)
4. Eisai Corporation of North America (1 from 4 patents)
5. Profectus Biosciences, Inc. (1 from 2 patents)
37 patents:
1. 8894989 - PARP inhibitor compounds, compositions and methods of use
2. 8883787 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP
3. 8629164 - Inhibitors of NF-κB
4. 8470825 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP
5. 8236802 - PARP inhibitor compounds, compositions and methods of use
6. 8129382 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
7. 8058275 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP
8. 7915280 - Compounds and their uses
9. 7820668 - Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP
10. 7750008 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
11. 7601719 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
12. 7456178 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
13. 7307080 - Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
14. 7268138 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
15. 7235557 - Compounds and their uses